Is DocuSign Stock Undervalued?
Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2023-03-31 | 2024-03-31 | |
| Income Statement | ||||||
| Revenue | $281.3M | $270.8M | $299.2M | $71.4M | $61.5M | |
| Gross Profit | $120.6M | $61.1M | $49.5M | $15.3M | $6.4M | |
| Operating Income | $113.8M | $54.3M | $42.4M | $12.9M | $4.2M | |
| EBITDA | $162.7M | $110M | $97.4M | $26.2M | $17.4M | |
| Diluted EPS | $1.14 | $0.24 | $0.17 | $0.01 | -$0.10 | |
| Period Ending | 2020-03-31 | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $20.9M | $99.6M | $188M | $198.2M | $204.9M | |
| Total Assets | $503.2M | $609.1M | $767.3M | $738M | $764.9M | |
| Current Liabilities | $72.7M | $82.9M | $93.3M | $108.5M | $95.5M | |
| Total Liabilities | $308.4M | $288.3M | $345.4M | $334.3M | $329.8M | |
| Total Equity | $194.8M | $320.8M | $421.8M | $403.7M | $435.2M | |
| Total Debt | -- | $197.1M | $187.4M | $199M | $174.3M | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2023-03-31 | 2024-03-31 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | $86M | $67.9M | $82.9M | $5.2M | $18.8M | |
| Cash From Investing | -$76.8M | -$88.3M | -$74.2M | -$16.4M | -$8.8M | |
| Cash From Financing | $8.9M | $7.7M | -$5.2M | $13.4M | -$229.9K | |
| Free Cash Flow | $6.9M | -$17.4M | $24.7M | -$11.1M | $9.9M | |
Victoria Gold Corp. is a gold mining company, which engages in the acquisition, evaluation, and development of mineral properties. Its project portfolio includes Dublin Gulch, Olive-Shamrock, Eagle Extension, Nugget, Raven, Lynx, Catto, and Popeye. The company was founded on September 21, 1981 and is headquartered in Toronto, Canada.
In the current month, VITFF has received 0 Buy ratings 0 Hold ratings, and 0 Sell ratings. The VITFF average analyst price target in the past 3 months is --.
According to analysts, the consensus estimate is that Victoria Gold Corp. share price will drop to -- per share over the next 12 months.
Analysts are divided on their view about Victoria Gold Corp. share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Victoria Gold Corp. is a Sell and believe this share price will rise from its current level to --.
The price target for Victoria Gold Corp. over the next 1-year time period is forecast to be -- according to 0 Wall Street analysts, 0 of them rate the stock a Buy, 0 rate the stock a Sell, and 0 analysts rate the stock a Hold.
According to Wall Street analysts, the consensus rating for Victoria Gold Corp. is a --. 0 of 0 analysts rate the stock a -- at this time.
You can purchase shares of Victoria Gold Corp. via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Victoria Gold Corp. shares.
Victoria Gold Corp. was last trading at $0.1100 per share. This represents the most recent stock quote for Victoria Gold Corp.. Yesterday, Victoria Gold Corp. closed at $0.1111 per share.
In order to purchase Victoria Gold Corp. stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
Signup to receive the latest stock alerts
Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…
Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…
Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…
Market Cap: $4.6T
P/E Ratio: 64x
Market Cap: $4T
P/E Ratio: 37x
Market Cap: $3.8T
P/E Ratio: 39x
Hut 8 Corp. [HUT] is up 0.65% over the past day.
Travere Therapeutics, Inc. [TVTX] is up 14.03% over the past day.
Structure Therapeutics, Inc. [GPCR] is down 2.36% over the past day.